imatinib mesylate has been researched along with Ectopic Lymph Nodes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, Y; Jiang, Q; Li, J; Lin, Q; Liu, J; Lu, W; Ma, L; Tao, P; Tong, H; Wang, J; Xue, R; Zhang, G; Zhang, Y | 1 |
1 other study(ies) available for imatinib mesylate and Ectopic Lymph Nodes
| Article | Year |
|---|---|
Tumor-associated tertiary lymphoid structure predicts postoperative outcomes in patients with primary gastrointestinal stromal tumors.
Topics: Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Neoplasm Recurrence, Local; Prognosis; Tertiary Lymphoid Structures | 2020 |